René‐Marc Flipo

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 475 citations · Full text

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

Jacques‐Eric Gottenberg, Philippe Ravaud, Thomas Bardin et al. · Arthritis & Rheumatism · 2010 · 296 citations

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Pierre‐Antoine Juge, Raphaël Borie, Caroline Kannengiesser et al. · European Respiratory Journal · 2017 · 225 citations · Full text

The ESPOIR cohort: A ten-year follow-up of early arthritis in France

Bernard Combe, Joëlle Bénessiano, Francis Bérenbaum et al. · Joint Bone Spine · 2007 · 177 citations

Rheumatoid Disorder, Rheumatology, Epidemiology +14